(UPDATE) Niraparib
Mirvetuximab Soravtasine-gynx (Elahere)
Olaparib
Bevacizumab
NCCN COVID-19 Resources Page
Rivkin Center for Ovarian Cancer
NCCN Guidelines for Patients®
Foundation for Women's Cancer